ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: PO1954

Neonatal AKI Is Associated with Impaired Renal Function at 24 Months of Age

Session Information

Category: Pediatric Nephrology

  • 1700 Pediatric Nephrology


  • Krom, Stephanie C., University of Rochester Medical Center, Rochester, New York, United States
  • Kent, Alison, University of Rochester Medical Center, Rochester, New York, United States
  • Rademacher, Erin, University of Rochester Medical Center, Rochester, New York, United States
  • Wang, Hongyue, University of Rochester Medical Center, Rochester, New York, United States

Neonatal acute kidney injury (nAKI) is common, occurring in up to 30% of neonatal intensive care admissions. However, there are currently no guidelines for nephrologic evaluation after the neonatal period. Our objective was to determine the incidence of renal dysfunction at 24-months of age and to identify associated risk factors following nAKI.


Retrospective single-center cohort study of infants with nAKI (defined as rise in creatinine (Cr) ≥ 0.3, abnormal initial Cr for gestational age, or abnormal rate of Cr decline) seen in pediatric nephrology clinic at 24-months. Abnormal estimated glomerular filtration rate (eGFR) (< 90 ml/min/1.73m2), hypertension (BP ≥ 95th%ile), proteinuria (TP/Cr > 0.5), and renal length (≥ the 95th or ≤ the 5th %ile) were correlated with high risk NICU events and exposures. Data was obtained by chart review. eGFR was calculated using cystatin C and creatinine separately, using the CKID cystatin C and the revised Schwartz equations, respectively. Data was analyzed using t-tests, Wilcoxon Rank Sum Test, or Chi-square as appropriate.


36/42 infants with history of nAKI referred to nephrology had a 24-month visit. 20 of 36 subjects (55.5%) had at least one renal abnormality, with 14 (39%) having eGFR < 90 ml/min/1.73m2 by cystatin C, 7/36 (19.4%) had proteinuria, 3/36 (8.3%) had hypertension, and 4/36 (11.1%) had abnormal renal length. 1/15 subjects with reduced GFR by cystatin C also had a reduced GFR by serum creatinine. Subjects with renal dysfunction at 24 months had a neonatal history of more vasopressors exposure days (mean, 4.5 vs 0.25, p = 0.002), more total diuretic days (mean 122 vs 51 p=0.03), were more likely to be taking a diuretic at discharge (n=11 vs n=3, p= 0.026), or to be of extremely low birth weight (ELBW < 1000 gm) (n=14 vs n=4, p= 0.007) compared to those without renal dysfunction.


The majority of children with nAKI had evidence of renal dysfunction at 24-month of age. Serum Cystatin C was more sensitive at identifying kidney dysfunction than creatinine alone. All children with nAKI should be referred for renal follow-up with a particular focus on children who were ELBW, required vasopressors, or had prolonged diuretic use in the neonatal period.